|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00782782 |
|
Date of registration:
|
26/10/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Vascular Sensitivity to Adrenergic Agonists in Patients With CHF and in Healthy Subjects
|
|
Scientific title:
|
Effect of Medications on Vascular Response in Patients With CHF and in Healthy Subjects |
|
Date of first enrolment:
|
August 2008 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Active, not recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00782782 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Mordechai Muszkat |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hadassah University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with congestive heart failure NYHA I-II
- Stable clinical condition
Exclusion Criteria:
- Resting systolic blood pressure < 100
- Resting heart rate < 50
- Hypersensitivity to dexmedetomidine, phenylephrine, isoproterenol, terbutaline
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Congestive Heart Failure
|
|
Primary Outcome(s)
|
|
vascular sensitivity (ED50) and response (Emax) to dexmedetomidine, phenylephrine, isoproterenol and terbutaline
[Time Frame: 3 weeks]
|
|
Secondary ID(s)
|
|
366-28.12.07
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|